 Subjects -> PHARMACY AND PHARMACOLOGY (Total: 575 journals)
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z | | The end of the list has been reached or no journals were found for your choice. |
|
|
- Evaluating the accuracy of extrapolated overall survival for
pembrolizumab: a comparison with long-term observed data in the Australian
reimbursement context-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Francis C. Dehle Kevin Phan Jerome Higgins Kate Applegarth Manoj Gambhir Colman B. Taylor a HTANALYSTS; Sydney, Australiab MSD, Macquarie Park, NSW, Australiac The George Institute for Global Health, Sydney, Australiad The University of New South Wales, Sydney, Australia
Pages: 1 - 8
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-04-04T11:31:01Z
DOI: 10.1080/14737167.2025.2478234
- New drug accessibility and budgetary impact in South Korea: policy
challenges and implications-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Se-Eun Hwang Yoon-A Jang Kyung-Min Lim Ji-Won Jung Jong Hyuk Lee College of Pharmacy; Chung-Ang University, Seoul, Republic of Korea
Pages: 1 - 9
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-04-02T11:12:05Z
DOI: 10.1080/14737167.2025.2487468
- Comprehensive economic value evaluation of adding tislelizumab to
first-line chemotherapy for patients with extensive-stage small cell lung
cancer in China-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Shan Zhao Shuo Kang a Department of Oncology; The Second Hospital of Hebei Medical University, Shijiazhuang, PR Chinab Medical Insurance Office, The Second Hospital of Hebei Medical University, Shijiazhuang, PR China
Pages: 1 - 7
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-03-28T08:25:20Z
DOI: 10.1080/14737167.2025.2483423
- COVID-19-related hospitalizations in Italy: an application of the
synthetic control method to investigate the trajectory of
diagnosis-related group 79 and its counterfactual during 2010–2021-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Carlo Lazzaro Giovanni Fattore Angelo Guido Corsico a Studio di Economia Sanitaria; Milan, Italyb Biology Therapeutics Department, University of Pavia, Pavia, Italy
Pages: 1 - 13
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-03-26T09:16:46Z
DOI: 10.1080/14737167.2025.2482661
- Cost-effectiveness of nintedanib versus pirfenidone in the treatment of
idiopathic pulmonary fibrosis: a systematic review-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Aziz Rezapour Mohammad Veysi-Sheikhrobat Aghdas Souresrafil Sajad Moeini Tayebe Roghani Abdollah Sayyad Ahmad Tahmasebi-Ghorrabi a Health Management; Health Promotion, School of Health, Occupational Environment Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Irand School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Pages: 1 - 9
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-03-25T04:21:53Z
DOI: 10.1080/14737167.2025.2480718
- Matching-adjusted indirect comparison and cost-effectiveness of
mitoxantrone hydrochloride liposome versus Chidamide in relapsed or
refractory peripheral T-cell lymphoma in China-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Ying Liu Xiaoning He School of Pharmaceutical Science; Data, Tianjin University, Tianjin, China
Pages: 1 - 10
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-03-25T03:38:00Z
DOI: 10.1080/14737167.2025.2482667
- Access and pricing of medicines for patients with rare diseases in the
European Union: an industry perspective. A 2025 update-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Giovanni Tafuri Andrea Bracco Jens Grueger a Value; Access & Policy, Apellis International GmbH, Zug, Switzerlandb Market Access, Madrigal Pharmaceuticals, Zug, Switzerlandc The Comparative Health Outcomes, Policy, Economics (CHOICE) Institute, University of Washington, Seattle, Washington, USAd Boston Consulting Group Zurich, Healthcare Practice Area, Zurich, Switzerland
Pages: 1 - 7
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-03-19T09:47:01Z
DOI: 10.1080/14737167.2025.2479131
- The impact of comprehensive public hospital reform on economic burden of
inpatients with chronic obstructive pulmonary disease: evidence from a
pilot city in western China-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Yanghaotian Wu Jingfu Qiu a School of Public Health; Chongqing Medical University, Chongqing, Chinab School of Public Health, Southwest Medical University, Luzhou, Chinac School of Public Health, Lanzhou University, Lanzhou, China
Pages: 1 - 11
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-03-18T06:52:36Z
DOI: 10.1080/14737167.2025.2480123
- Psychometric properties of outcome measures for freezing of gait in
Parkinson’s disease: a systematic review and meta-analysis-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Prisca Proietti Ilaria Ruotolo Alessandra Carlizza Alessandro Ugolini Giovanni Galeoto Giovanni Fabbrini Giovanni Sellitto a UniCamillus; International Medical University in Rome, Rome, Italyb Department of Human Neurosciences, Sapienza University, Rome, Italyc Department of Public Health Infectious Disease, Sapienza University, Rome, Italyd Private Practice, Empoli, FI, Italye IRCCS Neuromed, Pozzilli, Italy
Pages: 1 - 13
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-03-14T04:42:59Z
DOI: 10.1080/14737167.2025.2477473
- Indication-based pricing of the pharmaceuticals in Croatia: case-study
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Ana Bobinac Luka Vončina Ismar Velić Elizabeta Ribarić Vanesa Benković a Faculty of Economics; Pharmacoeconomics, University of Rijeka, Rijeka, Croatiab Faculty of Health Studies, University of Rijeka, Rijeka, Croatiac Market Access & Public Affairs Director, Novo Nordisk Hrvatska, Zagreb, Croatiad Andrija Stampar School of Public Health, Rockfellerova 4, University of Zagreb School of Medicine, Zagreb, Croatia
Pages: 1 - 8
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-03-14T02:53:01Z
DOI: 10.1080/14737167.2025.2478232
- Cost-effectiveness analysis of trilaciclib for reducing the incidence of
chemotherapy-induced myelosuppression among patients with extensive-stage
small cell lung cancer in China-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Nan Fang Xuan Xia Xiaoning He School of Pharmaceutical Science; Data, Tianjin University, Tianjin, China
Pages: 1 - 10
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-03-12T09:47:31Z
DOI: 10.1080/14737167.2025.2478241
- Preferences of nurses in the United Kingdom for attributes of pediatric
hexavalent vaccines: a discrete-choice experiment-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Christine Poulos Tomas Marcek Phani Chintakayala Marco Boeri Amy Francis Edith Langevin Tanaz Petigara Jenny O’Connor Salome Samant a RTI Health Solutions, Research Triangle Park, NC, USAb MCM Vaccine B.V; Leiden, The Netherlandsc RTI Health Solutions, Manchester, UKd RTI Health Solutions, Belfast, UKe Sanofi, Reading, Berkshire, UKf Sanofi, Lyon, Franceg Merck & Co. Inc, Rahway, NJ, USAh Goring & Woodcote Medical Practice, Reading, Berkshire, UK
Pages: 1 - 8
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-02-28T08:56:56Z
DOI: 10.1080/14737167.2025.2450352
- Patient-relevance of outcome measures in breast cancer clinical trials: a
cross-sectional comparative analysis of patient preferences and trials
conducted between 2014 and 2024-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Jasmijn Plooij Diana M.J. Delnoij a Erasmus School of Health Policy & Management; Erasmus University Rotterdam, Rotterdam, The Netherlandsb National Health Care Institute, Diemen, The Netherlands
Pages: 1 - 6
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-02-20T11:52:25Z
DOI: 10.1080/14737167.2025.2467379
- Evaluation of biological drug consumption in Italy during 2022: a
comparative analysis between two healthcare facilities-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Marcello Vaccaro Giacomo Polito Gabriele Bagaglini Maurizio Capuozzo Roberto Langella Eduardo Nava Andrea Zovi Francesco Ferrara a Pharmacy Unit; Pharmacy Department, Policlinico Umberto I, Rome, Italyb Pharmacy Unit, ASL Latina, Latina, Italyc Pharmaceutical department, Asl Napoli 3 Sud, Naples, Italyd Italian Society of Hospital Pharmacy (SIFO), SIFO Secretariat of the Lombardy Region, Milan, Italye Asl Napoli 3 Sud, Nola, Naples, Italyf School of Pharmacy, Università di Camerino, Camerino, Italy
Pages: 1 - 7
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-02-20T08:47:20Z
DOI: 10.1080/14737167.2025.2465445
- Cost comparison of F(ab’)2 and Fab antivenoms for pit viper envenomation
in the United States: a real-world analysis-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Walter Garcia-Ubbelohde Lia Pizzicato Keith J Boesen Swapna Munnangi Liucheng Shi Nicholas B. Hurst Mitchell DeKoven a Laboratorios Silanes; Ciudad de México, CDMX, Mexicob IQVIA, Falls Church, VA, USAc Rare Disease Therapeutics, Inc., Franklin, TN, USAd IQVIA, Wayne, PA, USAe Department of Emergency Medicine, The University of Arizona, College of Medicine - Tucson, Tucson, AZ, USAf Arizona Poison Drug Information Center, The University of Arizona, R. Ken Coit College of Pharmacy, Tucson, AZ, USA
Pages: 1 - 8
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-02-12T02:12:40Z
DOI: 10.1080/14737167.2025.2462236
- Autologous stem-cell transplantation and maintenance therapy for
transplant-eligible multiple myeloma patients: cost-effectiveness analysis
based on a network meta-analysis-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Weijia Wu Yannan Wang Yingting Lou Xiaoyuan Fan Wenqianzi Yang Fengyuan Tang Zixuan Zhao Hengjin Dong a Department of Science; Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou, Chinab Center for Clinical Pharmacy, Cancer Center, Clinical Research Institute, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, China
Pages: 1 - 11
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-02-05T12:22:10Z
DOI: 10.1080/14737167.2025.2461636
- Medical oncologists’ dance with international guidelines and national
reimbursement: insights from a survey in Türkiye-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Ozgur Tanriverdi Melek Ozdemir Emre Hafizoglu Taliha Guclu Elvina Almurodova Sait Kitapli Islam Cagri Bosna Tugba Dubektas-Canbek Utku Oflazoglu Ali Alkan Sabri Barutca a Department of Medical Oncology; Mugla Sıtkı Koçman University Faculty of Medicine, Mugla, Türkiyeb Department of Medical Oncology, Pamukkale University Faculty of Medicine, Denizli, Türkiyec Medical Oncology Clinic, Health Sciences University Van Education Research Hospital, Izmir, Türkiyef Department of Medical Oncology, Adnan Menderes University Faculty of Medicine, Aydin, Türkiye
Pages: 1 - 11
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-02-05T05:31:39Z
DOI: 10.1080/14737167.2025.2462238
- Cost-effectiveness of blood-based colorectal cancer screening – a
simulation model incorporating real-world longitudinal adherence-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Elifnur Yay Donderici Shaun P. Forbes Nicole J. Zhang Gregory Schafer Victoria M. Raymond Amar K. Das Craig Eagle AmirAli Talasaz William M. Grady a Guardant Health Inc; Redwood City, CA, USAb Fred Hutchinson Cancer Center, University of Washington School of Medicine, Seattle, WA, USA
Pages: 1 - 7
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-02-03T12:18:22Z
DOI: 10.1080/14737167.2025.2458044
- Budget impact of low-dose computed tomography screening for lung cancer in
Argentina-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Constanza Silvestrini Lucas Perelli Andrea Alcaraz Natalia Espinola Fernando Argento Department of Health Technology Assessment; Health Policy (IECS), Buenos Aires, Argentina
Pages: 1 - 8
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-30T10:15:08Z
DOI: 10.1080/14737167.2025.2460523
- How unprofessional behaviours between healthcare staff threaten patient
care and safety-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Justin Aunger Jill Maben Johanna I Westbrook a NIHR Midlands Patient Safety Research Collaboration; University of Birmingham, Birmingham, UKb School of Health Sciences, Faculty of Health Medical Sciences, University of Surrey, Guildford, UKc Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia
Pages: 1 - 4
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-30T01:41:34Z
DOI: 10.1080/14737167.2025.2460518
- Diabetes disparities in diabetes health care access and outcomes during
the COVID-19 pandemic in the United States-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Lixian Zhong Yanlei Ma Yelena Ionova Anjali Bhatt Ruben Vargas Timothy Banh Leslie Wilson a Department of Clinical Pharmacy; University of California San Francisco, San Francisco, CA, USAb School of Pharmacy, Texas A&M University, Kingsville, TX, USAc Department of Health Policy Management, Harvard TH Chan School of Public Health, Boston, MA, USAd Data Strategy & Analytics, Redica Systems, Pleasanton, CA, USAe School of Medicine, Texas A&M University, Bryan, TX, USA
Pages: 1 - 11
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-28T08:03:51Z
DOI: 10.1080/14737167.2025.2455383
- Cost-effectiveness analysis of trastuzumab emtansine for second-line
treatment of HER2+ advanced breast cancer in Singapore-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Wei Han Melvin Wong Raymond Ng Mohamed Ismail Abdul Aziz Benjamin Shao-Kiat Ong Kwong Ng a Agency for Care Effectiveness; Ministry of Health, Singaporeb Division of Medical Oncology, National Cancer Centre Singapore, Singapore
Pages: 1 - 9
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-22T01:02:21Z
DOI: 10.1080/14737167.2025.2456065
- Medication adherence in rheumatoid arthritis: implications for
cardiovascular disease risk and strategies to address in U.S. veterans-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Isaac D. Smith Bryant R. England Neha J. Pagidipati Hayden Bosworth a Department of Medicine; Division of Rheumatology Behavioral Sciences, Duke University School of Medicine, Durham, NC, USAj Duke University School of Nursing, Durham, NC, USA
Pages: 1 - 13
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-20T08:14:40Z
DOI: 10.1080/14737167.2025.2451141
- Value attributes of advanced therapy medicinal products: a documentary
analysis of comments received from stakeholders during reimbursement
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Nermina Ferizovic Ruth Plackett Caroline S. Clarke Rachael Hunter Nick Freemantle a Research Department of Primary Care; Population Health, University College London, London, UKb Comprehensive Clinical Trials Unit, University College London, London, UK
Pages: 1 - 17
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-20T06:08:32Z
DOI: 10.1080/14737167.2025.2455405
- Are quality-adjusted life years (QALYs) becoming more expensive' Evidence
from economic evaluations of diabetic therapeutics-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Yawen Jiang Wenjie Hu Bingxin Hu Huiqiao Gu Yuantian Cui Xinyu Zhao School of Public Health (Shenzhen); Sun Yat-sen University, Shenzhen, Guangdong, China
Pages: 1 - 7
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-17T12:16:04Z
DOI: 10.1080/14737167.2025.2451747
- A perspective on the use of patient-reported experience and
patient-reported outcome measures in ambulatory healthcare-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Ron D. Hays Denise D. Quigley a Department of Medicine; UCLA, Los Angeles, CA, USAb RAND Corporation, Santa Monica, CA, USA
Pages: 1 - 9
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-17T12:05:25Z
DOI: 10.1080/14737167.2025.2451749
- Methodological standards for comparative effectiveness research:
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Riddhi Doshi Victoria Divino Luke Greenwalt Mitchell DeKoven a Real World Solutions; IQVIA, Durham, NC, USAb Market Access Center of Excellence, IQVIA, Boston, MA, USA
Pages: 1 - 7
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-17T04:12:59Z
DOI: 10.1080/14737167.2025.2453503
- The socioeconomic burden of cervical cancer and its implications for
strategies required to achieve the WHO elimination targets-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Julia M. L. Brotherton Claire M. Vajdic Claire Nightingale a Evaluation; Evaluation Research Program, Kirby Institute, University of New South Wales, Kensington, NSW, Australia
Pages: 1 - 20
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-16T06:41:53Z
DOI: 10.1080/14737167.2025.2451732
- Cost-effectiveness of toripalimab plus chemotherapy versus chemotherapy as
first-line treatment for advanced non-small cell lung cancer in China: a
societal perspective-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Dai Lian Yi Yang Yuling Gan Dunming Xiao Yuliang Xiang Shan Jiang Yuanyuan Gu Yingyao Chen a School of Public Health; Fudan University, Shanghai, Chinab National Health Commission Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, Chinac Macquarie Business School, Australian Institute of Health Innovation, Macquarie University Centre for the Health Economy, Macquarie University, Sydney, New South Wales, Australia
Pages: 1 - 10
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-16T05:45:58Z
DOI: 10.1080/14737167.2025.2451748
- The Lebanese health economic evaluation guideline
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Caroline Daccache Rana Rizk Mickaël Hiligsmann Silvia M.A.A. Evers Rita Karam a Department of Health Services Research; Care Medical Sciences, Lebanese University, Hadath, Lebanon
Pages: 1 - 14
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-15T09:54:48Z
DOI: 10.1080/14737167.2025.2450322
- A retrospective observational analysis of the real-world care pathway of
people with hereditary transthyretin amyloidosis with polyneuropathy in
Italy-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Silvia Calabria Giulia Ronconi Letizia Dondi Leonardo Dondi Irene Dell’Anno Carlo Piccinni Immacolata Esposito Alice Addesi Marco Gnesi Nicola Cosentino Marco D’Amelio Nello Martini Aldo Pietro Maggioni a Research; Health Srl, Roma, Italyc Medical Evidence, Biopharmaceuticals Medical, AstraZeneca S.p.A, Milano, Italyd Medical Affairs, Biopharmaceuticals Medical, AstraZeneca S.p.A, Milano, Italye Value & Access, Biopharmaceuticals, AstraZeneca S.p.A, Milano, Italyf ANMCO Research Center, Heart Care Foundation, Firenze, Italy
Pages: 1 - 8
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-15T05:47:59Z
DOI: 10.1080/14737167.2025.2450310
- The short-term impact of copayment reductions for government subsidised
medicines in Australia-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Mohammad Afshar Ali Firouzeh Noghrehchi Christine Y. Lu a School of Pharmacy; Faculty of Medicine the Northern Sydney Local Health District, Sydney, Australiac Department of Pharmacy, Royal North Shore Hospital, St Leonards, Australia
Pages: 1 - 10
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-13T07:46:02Z
DOI: 10.1080/14737167.2025.2451140
- Cost effectiveness of obstructive sleep apnea therapies: a systematic
review and meta-analysis of cost utility studies-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: S. Sajith Kumar G. Suchitra Lakshmi Aamir Sohail Kayala Venkata Jagadeesh Bhavani Shankara Bagepally a Health Technology Assessment in India (HTAIn) Regional Resource Hub; ICMR-National Institute of Epidemiology, Chennai, Indiab National Cancer Grid, Tata Memorial Hospital, Mumbai, Maharashtra, Indiac Health Technology Assessment in India (HTAIn) Regional Resource Centre, Department of Instrumentation Applied Physics, Indian Institute of Science (IISc), Bengaluru, Indiad Health Technology Assessment in India (HTAIn) Secretariat, Department of Health Research, MoHFW, Government of India, New Delhi, Indiae Health Economics & Reimbursement, India Medtronic Pvt. Ltd, New Delhi, India
Pages: 1 - 9
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-13T05:43:45Z
DOI: 10.1080/14737167.2025.2451733
- Biologics in the treatment of active Psoriatic arthritis in China: a
network meta-analysis and cost-effectiveness analysis-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Ouyang Xie Meiyu Wu Andong Li Kehui Meng Heng Xiang Chongqing Tan Liubao Peng Yan Ge Xiaomin Wan a Department of Pharmacy; The Second Xiangya Hospital, Central South University, Changsha, Hunan, Chinab Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, Chinac Department of Rheumatology Immunology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, Chinad Clinical Medical Research Center for Systemic Autoimmune Diseases in Hunan Province, Changsha, China
Pages: 1 - 9
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-10T07:03:19Z
DOI: 10.1080/14737167.2025.2451740
- Challenges in resource allocation of diagnostic tests in Spain
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Reyes Lorente Fernando Antonanzas Department of Economics; University of La Rioja, Logrono, Spain
Pages: 1 - 3
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2025-01-09T12:03:04Z
DOI: 10.1080/14737167.2025.2451743
- Clinical and economic impact analysis of viscosupplementation with hylan
G-F 20 versus hyaluronic acids and no viscosupplementation for the
treatment of knee osteoarthritis in Colombia-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Eliana C. Vásquez Melo Pieralessandro Lasalvia Lina Maria Gómez Espitia Luz Karime Osorio Arango Sergio Londoño Angie Upegui a Departamento economía de la salud; Neuroeconomix, Bogotá, Colombiab Departamento Medicina basada en la evidencia, Neuroeconomix, Bogotá, Colombiac Department of Health Economics Value Assessment COPAC, Sanofi, Bogotá
Pages: 1 - 8
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2024-12-30T10:33:25Z
DOI: 10.1080/14737167.2024.2442461
- Disparities in Respiratory Syncytial Virus Risk Factors, Diagnosis, and
Outcomes in Adults by Race, Ethnicity, and Other Social Determinants of
Health in the United States-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Emily K. Horn Elizabeth M. La Meryem Bektas Shahnaz Khan Susan I. Gerber a Health Economics & Outcomes Research; US Medical Affairs, Vaccines, GSK, Philadelphia, PA, USAb RTI Health Solutions, Research Triangle Park, Durham, NC, USAc US Medical Affairs, Vaccines, GSK, Philadelphia, PA, USA
Pages: 1 - 13
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2024-12-25T05:36:29Z
DOI: 10.1080/14737167.2024.2441867
- Reimagining pharmacoeconomics in the age of artificial intelligence:
opportunities, challenges, and future directions-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Majid Ali Department of Basic Sciences; College of Medicine, Sulaiman Al-Rajhi University, Al-Bukayriyah, Saudi Arabia
Pages: 1 - 4
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2024-12-19T11:19:40Z
DOI: 10.1080/14737167.2024.2442466
- Correction
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 1 - 1
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2024-11-08T05:08:07Z
DOI: 10.1080/14737167.2024.2426849
- Correction
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 1 - 1
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2024-11-05T04:53:00Z
DOI: 10.1080/14737167.2024.2424062
- Patients’ health related quality of life after massive weight loss
reconstruction in the Netherlands-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Guus van Uittert Maarten Hoogbergen Charlotte Beaudart Nannan Li Mijke Boers Mickaël Hiligsmann a Faculty of Health; Medicine Life Sciences, Maastricht University, Maastricht, The Netherlandsf Department Plastic Surgery, Rijnstate Hospital, Arnhem, The Netherlands
Pages: 1 - 10
Abstract: .
Citation: Expert Review of Pharmacoeconomics & Outcomes Research
PubDate: 2024-08-22T05:09:31Z
DOI: 10.1080/14737167.2024.2393328
|
Subscription journal
